| Q34341900 | A first-generation multi-functional cytokine for simultaneous optical tracking and tumor therapy |
| Q39744489 | A novel molecule integrating therapeutic and diagnostic activities reveals multiple aspects of stem cell-based therapy. |
| Q34979703 | A urokinase receptor-Bim signaling axis emerges during EGFR inhibitor resistance in mutant EGFR glioblastoma |
| Q35653261 | Antiangiogenic variant of TSP-1 targets tumor cells in glioblastomas |
| Q37140126 | Assessment of therapeutic efficacy and fate of engineered human mesenchymal stem cells for cancer therapy |
| Q33753135 | Bi-specific molecule against EGFR and death receptors simultaneously targets proliferation and death pathways in tumors |
| Q39012723 | Chemotactic responses of neural stem cells to SDF-1α correlate closely with their differentiation status |
| Q38960128 | Combination of systemic chemotherapy with local stem cell delivered S-TRAIL in resected brain tumors |
| Q54592798 | Differentiation of neural stem cells influences their chemotactic responses to vascular endothelial growth factor. |
| Q39188017 | Dynamics of focal adhesions and reorganization of F-actin in VEGF-stimulated NSCs under varying differentiation states. |
| Q30843565 | Electrospun nanofibrous scaffolds increase the efficacy of stem cell-mediated therapy of surgically resected glioblastoma |
| Q36695971 | Encapsulated therapeutic stem cells implanted in the tumor resection cavity induce cell death in gliomas |
| Q34444939 | Engineering toxin-resistant therapeutic stem cells to treat brain tumors |
| Q94660275 | Generation and Profiling of Tumor-Homing Induced Neural Stem Cells from the Skin of Cancer Patients |
| Q47405412 | Getting Closer to an Effective Intervention of Ischemic Stroke: The Big Promise of Stem Cell |
| Q39725116 | Human stem cells expressing novel TSP-1 variant have anti-angiogenic effect on brain tumors. |
| Q37352907 | In Vivo Cellular Imaging for Translational Medical Research |
| Q39940650 | In vivo bioluminescence imaging in an experimental mouse model for dendritic cell based immunotherapy against malignant glioma. |
| Q37791278 | In vivo imaging in cancer |
| Q33519142 | In vivo neural stem cell imaging: current modalities and future directions. |
| Q39397148 | Interleukin-1β and transforming growth factor-β cooperate to induce neurosphere formation and increase tumorigenicity of adherent LN-229 glioma cells. |
| Q38515294 | Lentiviral vectors as tools to understand central nervous system biology in mammalian model organisms. |
| Q59131876 | MR imaging tracking of inflammation-activatable engineered neutrophils for targeted therapy of surgically treated glioma |
| Q36092724 | Mesenchymal stem cells engineered for cancer therapy |
| Q37938466 | Migration and fate of therapeutic stem cells in different brain disease models. |
| Q36512525 | Multimechanistic tumor targeted oncolytic virus overcomes resistance in brain tumors |
| Q39012877 | Multiple lesions in receptor tyrosine kinase pathway determine glioblastoma response to pan-ERBB inhibitor PF-00299804 and PI3K/mTOR dual inhibitor PF-05212384. |
| Q33704489 | Neural stem cell therapy for cancer |
| Q37096766 | Neural stem cells target intracranial glioma to deliver an oncolytic adenovirus in vivo |
| Q38353261 | Opportunities and challenges: stem cell-based therapy for the treatment of ischemic stroke. |
| Q38974708 | PET imaging of glioblastoma multiforme EGFR expression for therapeutic decision guidance. |
| Q36129857 | Probe-Based Confocal Laser Endomicroscopy for Imaging TRAIL-Expressing Mesenchymal Stem Cells to Monitor Colon Xenograft Tumors In Vivo |
| Q34092169 | Promoted Growth of Brain Tumor by the Transplantation of Neural Stem/Progenitor Cells Facilitated by CXCL12. |
| Q36913828 | Real-time imaging of the dynamics of death receptors and therapeutics that overcome TRAIL resistance in tumors |
| Q36543537 | Real-time multi-modality imaging of glioblastoma tumor resection and recurrence. |
| Q33622514 | Stem cell transplantation in brain tumors: a new field for molecular imaging? |
| Q38855638 | Stem cell-based therapies for tumors in the brain: are we there yet? |
| Q40122051 | Stem cell-released oncolytic herpes simplex virus has therapeutic efficacy in brain metastatic melanomas |
| Q42218017 | Stem cells loaded with multimechanistic oncolytic herpes simplex virus variants for brain tumor therapy. |
| Q35974503 | Targeting breast to brain metastatic tumours with death receptor ligand expressing therapeutic stem cells |
| Q35153149 | Targeting c-Met receptor overcomes TRAIL-resistance in brain tumors |
| Q37356520 | Targeting multiple pathways in gliomas with stem cell and viral delivered S-TRAIL and Temozolomide |
| Q34986247 | The mTOR kinase inhibitors, CC214-1 and CC214-2, preferentially block the growth of EGFRvIII-activated glioblastomas |
| Q49936618 | Therapeutic Neural Stem Cells Engineered During Different Stages of Reprogramming Reveal Varying Therapeutic Efficacies |
| Q39198277 | Therapeutic efficacy and fate of bimodal engineered stem cells in malignant brain tumors |
| Q40178043 | Therapeutic targeting of chemoresistant and recurrent glioblastoma stem cells with a proapoptotic variant of oncolytic herpes simplex virus. |
| Q34263640 | Tracking stem cells for cellular therapy in stroke |
| Q38950411 | Translation of the ecological trap concept to glioma therapy: the cancer cell trap concept |
| Q48329121 | Tumor-homing cytotoxic human induced neural stem cells for cancer therapy. |
| Q38730790 | Use of genetically engineered stem cells for glioma therapy |
| Q38737932 | Viral vector-based tools advance knowledge of basal ganglia anatomy and physiology |
| Q41920847 | microRNA-7 upregulates death receptor 5 and primes resistant brain tumors to caspase-mediated apoptosis |